Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Multiple signaling pathways related to inflammation" is not a single molecule, receptor, or canonical therapeutic target. Instead, it refers collectively to several intracellular and intercellular signal transduction cascades that regulate inflammatory responses. Key examples include the nuclear factor kappa B (NF‑κB), mitogen‑activated protein kinase (MAPK), Janus kinase/signal transducer and activator of transcription (JAK/STAT), and phosphoinositide 3‑kinase/protein kinase B (PI3K/Akt) pathways[1][3][4]. These networks coordinate immune cell activation, cytokine production, cell survival/death decisions, and tissue responses during infection or injury. Dysregulation can lead to chronic inflammatory diseases and contribute to cancer progression[1][2][5]. While many drugs modulate components of these cascades—such as inhibitors targeting NF‑κB or JAK kinases—the term itself does not denote an actionable drug target but rather an area encompassing multiple potential targets within immunology and pharmacology[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple signaling pathways related to inflammation.